Literature DB >> 12218176

Integrated classification of lung tumors and cell lines by expression profiling.

Carl Virtanen1, Yuichi Ishikawa, Daisuke Honjoh, Mami Kimura, Miyuki Shimane, Tatsu Miyoshi, Hitoshi Nomura, Michael H Jones.   

Abstract

The utility of cancer cell lines depends largely on their accurate classification, commonly based on histopathological diagnosis of the cancers from which they were derived. However, because cancer is often heterogeneous, the cell line, which also has the opportunity to alter in vitro, may not be representative. Yet without the overall architecture used in histopathological diagnosis of fresh samples, reclassification of cell lines has been difficult. Gene-expression profiling accurately reproduces histopathological classification and is readily applicable to cell lines. Here, we compare the gene-expression profiles of 41 cell lines with 44 tumors from lung cancer. These profiles were generated after hybridization of samples to four replicate 7,685-element cDNA microarrays. After removal of genes that were uniformly up- or down-regulated in fresh compared with cell-line samples, cluster analysis produced four major branch groups. Within these major branches, fresh tumor samples essentially clustered according to pathological type, and further subclusters were seen for both adenocarcinoma (AC) and small cell lung carcinoma (SCLC). Four of eight squamous cell carcinoma (SCC) cell lines clustered with fresh SCC, and 11 of 13 SCLC cell lines grouped with fresh SCLC. In contrast, although none of the 11 AC cell lines clustered with AC tumors, three clustered with SCC tumors and six with SCLC tumors. Although it is possible that preexisting SCC or SCLC cells are being selected from AC tumors after establishment of cell lines, we propose that, even in situ, AC will ultimately progress toward one of two poorly differentiated phenotypes with expression profiles resembling SCC or SCLC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12218176      PMCID: PMC129449          DOI: 10.1073/pnas.192240599

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Issues in cDNA microarray analysis: quality filtering, channel normalization, models of variations and assessment of gene effects.

Authors:  G C Tseng; M K Oh; L Rohlin; J C Liao; W H Wong
Journal:  Nucleic Acids Res       Date:  2001-06-15       Impact factor: 16.971

2.  Stathmin family proteins display specific molecular and tubulin binding properties.

Authors:  E Charbaut; P A Curmi; S Ozon; S Lachkar; V Redeker; A Sobel
Journal:  J Biol Chem       Date:  2001-02-15       Impact factor: 5.157

3.  Gene expression profiles of laser-captured adjacent neuronal subtypes.

Authors:  L Luo; R C Salunga; H Guo; A Bittner; K C Joy; J E Galindo; H Xiao; K E Rogers; J S Wan; M R Jackson; M G Erlander
Journal:  Nat Med       Date:  1999-01       Impact factor: 53.440

4.  Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer.

Authors:  J B Welsh; P P Zarrinkar; L M Sapinoso; S G Kern; C A Behling; B J Monk; D J Lockhart; R A Burger; G M Hampton
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

5.  Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma.

Authors:  T Niki; S Iba; M Tokunou; T Yamada; Y Matsuno; S Hirohashi
Journal:  Clin Cancer Res       Date:  2000-06       Impact factor: 12.531

6.  Identification of tumor markers in models of human colorectal cancer using a 19,200-element complementary DNA microarray.

Authors:  P Hegde; R Qi; R Gaspard; K Abernathy; S Dharap; J Earle-Hughes; C Gay; N U Nwokekeh; T Chen; A I Saeed; V Sharov; N H Lee; T J Yeatman; J Quackenbush
Journal:  Cancer Res       Date:  2001-11-01       Impact factor: 12.701

7.  Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung.

Authors:  G Pelosi; F Fraggetta; F Pasini; P Maisonneuve; A Sonzogni; A Iannucci; A Terzi; E Bresaola; F Valduga; C Lupo; G Viale
Journal:  Am J Surg Pathol       Date:  2001-03       Impact factor: 6.394

8.  Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses.

Authors:  A Bhattacharjee; W G Richards; J Staunton; C Li; S Monti; P Vasa; C Ladd; J Beheshti; R Bueno; M Gillette; M Loda; G Weber; E J Mark; E S Lander; W Wong; B E Johnson; T R Golub; D J Sugarbaker; M Meyerson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-13       Impact factor: 11.205

9.  Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer.

Authors:  T R Hughes; M Mao; A R Jones; J Burchard; M J Marton; K W Shannon; S M Lefkowitz; M Ziman; J M Schelter; M R Meyer; S Kobayashi; C Davis; H Dai; Y D He; S B Stephaniants; G Cavet; W L Walker; A West; E Coffey; D D Shoemaker; R Stoughton; A P Blanchard; S H Friend; P S Linsley
Journal:  Nat Biotechnol       Date:  2001-04       Impact factor: 54.908

10.  A comparison of gene expression signatures from breast tumors and breast tissue derived cell lines.

Authors:  D T Ross; C M Perou
Journal:  Dis Markers       Date:  2001       Impact factor: 3.434

View more
  36 in total

1.  Osteopontin is up-regulated and associated with neutrophil and macrophage infiltration in glioblastoma.

Authors:  Nadia A Atai; Manju Bansal; Cheungh Lo; Joost Bosman; Wikky Tigchelaar; Klazien S Bosch; Ard Jonker; Philip C De Witt Hamer; Dirk Troost; Christopher A McCulloch; Vincent Everts; Cornelis J F Van Noorden; Jaro Sodek
Journal:  Immunology       Date:  2010-08-17       Impact factor: 7.397

2.  A clinical prognostic prediction of lymph node-negative breast cancer by gene expression profiles.

Authors:  Dingfeng Jiang; Naiqing Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-08       Impact factor: 4.553

3.  Metagene projection for cross-platform, cross-species characterization of global transcriptional states.

Authors:  Pablo Tamayo; Daniel Scanfeld; Benjamin L Ebert; Michael A Gillette; Charles W M Roberts; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-27       Impact factor: 11.205

Review 4.  Genomics of lung cancer.

Authors:  Alain C Borczuk; Rebecca L Toonkel; Charles A Powell
Journal:  Proc Am Thorac Soc       Date:  2009-04-15

Review 5.  Clinical uses of microarrays in cancer research.

Authors:  Carl Virtanen; James Woodgett
Journal:  Methods Mol Med       Date:  2008

6.  Chemical-genetic analysis of cyclin dependent kinase 2 function reveals an important role in cellular transformation by multiple oncogenic pathways.

Authors:  Dai Horiuchi; Noelle E Huskey; Leonard Kusdra; Lara Wohlbold; Karl A Merrick; Chao Zhang; Katelyn J Creasman; Kevan M Shokat; Robert P Fisher; Andrei Goga
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-03       Impact factor: 11.205

7.  p52-Independent nuclear translocation of RelB promotes LPS-induced attachment.

Authors:  T Saito; C Y Sasaki; L J Rezanka; P Ghosh; D L Longo
Journal:  Biochem Biophys Res Commun       Date:  2009-11-10       Impact factor: 3.575

8.  Comparison of lung cancer cell lines representing four histopathological subtypes with gene expression profiling using quantitative real-time PCR.

Authors:  Takashi Watanabe; Tomohiro Miura; Yusuke Degawa; Yuna Fujita; Masaaki Inoue; Makoto Kawaguchi; Chie Furihata
Journal:  Cancer Cell Int       Date:  2010-01-21       Impact factor: 5.722

9.  Comparative Membranome expression analysis in primary tumors and derived cell lines.

Authors:  Paolo Uva; Armin Lahm; Andrea Sbardellati; Anita Grigoriadis; Andrew Tutt; Emanuele de Rinaldis
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

10.  Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1.

Authors:  Lauren Averett Byers; Jing Wang; Monique B Nilsson; Junya Fujimoto; Pierre Saintigny; John Yordy; Uma Giri; Michael Peyton; You Hong Fan; Lixia Diao; Fatemeh Masrorpour; Li Shen; Wenbin Liu; Boris Duchemann; Praveen Tumula; Vikas Bhardwaj; James Welsh; Stephanie Weber; Bonnie S Glisson; Neda Kalhor; Ignacio I Wistuba; Luc Girard; Scott M Lippman; Gordon B Mills; Kevin R Coombes; John N Weinstein; John D Minna; John V Heymach
Journal:  Cancer Discov       Date:  2012-09-06       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.